Arto Mannermaa

researcher

Arto Mannermaa is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0001-8250-1930

P108employerUniversity of Eastern FinlandQ2093139
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q3601638611q13 is a susceptibility locus for hormone receptor positive breast cancer
Q3587156719p13.1 is a triple-negative-specific breast cancer susceptibility locus
Q338488952q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy
Q360214067q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium
Q371698739q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
Q57250674A common coding variant in CASP8 is associated with breast cancer risk
Q35755874A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer
Q45181384A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability
Q37192589A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication
Q37619303A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium
Q92711687A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
Q72427562A point mutation in the putative TATA box, detected in nondiseased individuals and patients with hereditary breast cancer, decreases promoter activity of the 17 beta-hydroxysteroid dehydrogenase type 1 gene 2 (EDH17B2) in vitro
Q35870483A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients
Q55043120A recurrent mutation in PALB2 in Finnish cancer families.
Q72319861A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele
Q57305942A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
Q44443237A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.
Q48410982Absence of association between an intercellular adhesion molecule 1 gene E469K polymorphism and Alzheimer's disease in Finnish patients
Q61948755Abstract 3266: Expression quantitative trait locus analysis of triple negative breast cancer
Q39437211Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers
Q53210396Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele.
Q53348411An association between a subset of Finnish late-onset Alzheimer's disease and alpha2-macroglobulin.
Q35681656Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis
Q33947477Antenatal gene tests in low-risk pregnancies: molecular screening for aspartylglucosaminuria (AGU) and infantile neuronal ceroid lipofuscinosis (INCL) in Finland
Q73592923Antenatal genetic screening for congenital nephrosis
Q73152217Apolipoprotein E alleles in women with intrahepatic cholestasis of pregnancy
Q35399356Apolipoprotein E alleles in women with pre-eclampsia
Q28216782Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease
Q53202168Apolipoprotein E polymorphism and Alzheimer's disease in eastern Finland.
Q53322695Apolipoprotein E polymorphism in patients with different neurodegenerative disorders.
Q41465811Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma
Q34613673Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
Q35218520Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy
Q45979098Association analysis identifies 65 new breast cancer risk loci.
Q33828680Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival
Q42718636Association of CYP46 intron 2 polymorphism in Finnish Alzheimer's disease samples and a global scale summary
Q37292963Association of ESR1 gene tagging SNPs with breast cancer risk
Q37684672Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.
Q37268494Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Q114182713Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
Q35022847Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies
Q35532898Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium
Q57056093Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
Q38914005BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer
Q37002955BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
Q46697376Beta-amyloid deposition in brains of subjects with diabetes
Q46115524Body mass index and breast cancer survival: a Mendelian randomization analysis
Q100457582Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
Q34327945Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
Q35940158Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
Q37406868Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functions
Q57305977Breast-Cancer Risk in Families With Mutations in PALB2
Q34148873Breast-cancer risk in families with mutations in PALB2
Q47719844Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients
Q36449203CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer
Q52017293Carrier diagnosis of the fragile X syndrome--a challenge in antenatal clinics.
Q33677756Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility
Q71041611Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism
Q53305404Combined risk effects of IDE and NEP gene variants on Alzheimer disease.
Q35891162Common breast cancer susceptibility loci are associated with triple-negative breast cancer
Q35794653Common germline polymorphisms associated with breast cancer-specific survival
Q34379032Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Q31082788Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q34181322Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer
Q57278898Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q30660858Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer
Q52054236Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele.
Q38354157Deletion in the FMR1 gene in a fragile-X male
Q55110745E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.
Q57250672Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk
Q53270093Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women.
Q51766497Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.
Q35653910Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk
Q36720821Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors
Q35064451Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Q37342144Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Q37394076FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome
Q42683589FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population
Q37594336FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
Q51985838Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies.
Q37236216Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).
Q36111237Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus
Q35524465Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Q61230414Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes
Q92480972Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Q39844032Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer
Q36248936Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk
Q34903062Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Q37367871Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Q57305889Finnish Fanconi anemia mutations and hereditary predisposition to breast and prostate cancer
Q34979715Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium
Q37369973Fragile-X: neuropsychological test performance, CGG triplet repeat lengths, and hippocampal volumes
Q57278925Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas
Q114182808Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
Q36124728Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Q36742577Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
Q57305903Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility
Q54395614GASC1 expression in lung carcinoma is associated with smoking and prognosis of squamous cell carcinoma.
Q40137431Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium
Q33589487Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes
Q57305900Genetic Polymorphisms and Protein Expression of NRF2 and Sulfiredoxin Predict Survival Outcomes in Breast Cancer
Q33197201Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p.
Q45279088Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease
Q37739048Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
Q35925620Genetic predisposition to ductal carcinoma in situ of the breast
Q35151684Genetic predisposition to in situ and invasive lobular carcinoma of the breast
Q35179897Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Q43497584Genetic variation in apolipoprotein D and Alzheimer's disease
Q34378972Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade
Q36422109Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium
Q30000080Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent
Q36842233Genome-wide association analysis identifies three new breast cancer susceptibility loci
Q35996692Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Q63681757Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
Q24622610Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Q29417100Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
Q95329367Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
Q24645441Genome-wide association study identifies novel breast cancer susceptibility loci
Q64040390Genome-wide association study of germline variants and breast cancer-specific mortality
Q53349500Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland.
Q59566871Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility
Q38823212Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk
Q96432094Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
Q114182677Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
Q36276540Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
Q53258567Heparan sulfate proteoglycan 2 polymorphism in Alzheimer's disease and correlation with neuropathology.
Q33330850Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics
Q36547888Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers
Q96821555High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival
Q37121271High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium
Q34475807Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer
Q41483086Human familial and sporadic breast cancer: analysis of the coding regions of the 17 beta-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay
Q44168152Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival
Q35102646Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Q36720814Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
Q53341379Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: an Alu core sequence-stimulated recombination?
Q36859142Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
Q36086247Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Q34038964Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions
Q36014067Identification of novel genetic markers of breast cancer survival
Q46103372Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Q48087910Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects
Q44430058Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer
Q43075276Increased risk of sensorineural hearing loss and migraine in patients with a rare mitochondrial DNA variant 4336A>G in tRNAGln
Q35104068Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Q43232447Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population
Q53354359Interleukin 1 alpha gene polymorphism as a susceptibility factor in Alzheimer's disease and its influence on the extent of histopathological hallmark lesions of Alzheimer's disease.
Q34898735Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors
Q44188638Is the presenilin-1 E318G missense mutation a risk factor for Alzheimer's disease?
Q47190168Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium
Q41581759KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes
Q57191573Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair
Q28267893Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair
Q29416989Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Q48114226Linkage disequilibrium in the 13q12 region in Finnish late onset Alzheimer's disease patients
Q36318321Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism
Q35642678Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival
Q35119701Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
Q47812698MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males
Q58769239Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls
Q51015419Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer.
Q114182490Mendelian randomisation study of smoking exposure in relation to breast cancer risk
Q34497352MicroRNA related polymorphisms and breast cancer risk
Q47996260Microsatellite marker association at chromosome region 2p13 in Finnish patients with preeclampsia and obstetric cholestasis suggests a common risk locus
Q44436193Midlife income, occupation, APOE status, and dementia: a population-based study
Q34123806Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls
Q47989626Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia
Q42706074MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen
Q57232775Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland
Q36897003Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Q46567991NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer
Q37356243Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Q30374367No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Q37079859No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing
Q33495389Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression
Q34351474Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer
Q28584533PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Q47143943PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.
Q36184231PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2.
Q34289136Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche
Q112572520Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
Q37307937Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium
Q27851443Penetrance analysis of the PALB2 c.1592delT founder mutation
Q36873786Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium
Q62583133Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q36308550Polymorphism in the tumor necrosis factor-alpha gene in women with preeclampsia
Q36066735Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression
Q34552678Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients
Q47779309Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease
Q53365689Possible association of nicastrin polymorphisms and Alzheimer disease in the Finnish population.
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q51973695Prenatal diagnosis of fragile X syndrome and the risk of expansion of a premutation.
Q37350137Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups
Q53337548Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.
Q55508030Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Q90242034Publisher Correction: Shared heritability and functional enrichment across six solid cancers
Q34425705RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability
Q36009422RAD51B in Familial Breast Cancer
Q48229615Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer
Q35155449Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Q28301674Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish population
Q49226587Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients.
Q45951126Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.
Q37300024Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
Q50849173SIP1 predicts progression and poor prognosis in pharyngeal squamous cell carcinoma.
Q36545934SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival
Q33735332SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele
Q42934843ST14 gene variant and decreased matriptase protein expression predict poor breast cancer survival
Q34307873SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?
Q57278919Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families
Q71675581Screening for amyloid beta precursor protein codon 665, 670/671 and 717 mutations in Finnish patients with Alzheimer's disease
Q44070760Seladin-1 transcription is linked to neuronal degeneration in Alzheimer's disease
Q61118451Shared heritability and functional enrichment across six solid cancers
Q64004349Shared heritability and functional enrichment across six solid cancers
Q51006098Spectral analysis of EEG in Alzheimer's disease: relation to apolipoprotein E polymorphism.
Q33566957TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer
Q49817640The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.
Q91178389The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Q35781316The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients
Q36917100The UGT1A6_19_GG genotype is a breast cancer risk factor
Q34144358The extent of linkage disequilibrium in four populations with distinct demographic histories
Q35004850The gene for 17 beta-hydroxysteroid dehydrogenase maps to human chromosome 17, bands q12-q21, and shows an RFLP with ScaI.
Q36142060The role of genetic breast cancer susceptibility variants as prognostic factors
Q43850081Transcription factor snail1 expression and poor survival in pharyngeal squamous cell carcinoma
Q33821467Transcription factors zeb1, twist and snai1 in breast carcinoma
Q89961489Transcriptome-wide association study of breast cancer risk by estrogen-receptor status
Q33990838Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression
Q34143985Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia
Q92994868Two truncating variants in FANCC and breast cancer risk
Q33910850Type II transmembrane serine protease gene variants associate with breast cancer
Q50592574Vimentin-ERK Signaling Uncouples Slug Gene Regulatory Function.
Q52052697Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes.
Q40706757Wide scope prenatal diagnosis at Kuopio University Hospital 1997-1998: integration of gene tests and fetal karyotyping
Q57278886XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancer
Q37414133rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk
Q28534781Γ-secretase components as predictors of breast cancer outcome

Search more.